This article examines the key differences between primary and secondary screening in drug discovery, detailing how primary ...

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...

Abstract: Recent breakthroughs in reconfigurable intelligent surface (RIS) technology are reshaping next-generation wireless networks. In multi-RIS deployments, however, the received signal becomes a ...

Wanna see a trick? Give us any topic and we can tie it back to the economy. At Planet Money, we explore the forces that shape our lives and bring you along for the ride. Don't just understand the ...